Association of Aurora A and gamma-tubulin expression in astrocytomas and patient survival

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114–23.
   PubMed Web of Science ®Google Scholar
• Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, et al. Validation and predictive power of radiation therapy oncology group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys. 1998;40:51–5.
   PubMed Web of Science ®Google Scholar
• Hartmann C, Nümann A, Mueller W, Holtkamp N, Simon M, von Deimling A. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. Int J Cancer. 2004;108:839–44.
   PubMed Web of Science ®Google Scholar
• Kamnasaran D, Qian B, Hawkins C, Stanford WL, Guha A. GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model. Proc Natl Acad Sci USA. 2007;104:8053–58.
   PubMed Web of Science ®Google Scholar
• Karges W, Karges B, Ludwig L, Heidemann PH. Bi-allelic inactivation of the MEN1 tumor suppressor gene in human grade II astrocytoma. Cancer Lett. 2003;196:23–7.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, et al. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell. 2005;8:119–30.
   PubMed Web of Science ®Google Scholar
• Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 2003;63:1398–404.
   PubMed Web of Science ®Google Scholar
• Lingle WL, Barrett SL, Negron VC, D’Assoro AB, Boeneman K, Liu W, et al. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA. 2002;99:1978–83.
   PubMed Web of Science ®Google Scholar
• Marumoto T, Honda S, Hara T, Nitta M, Hirota T, Kohmura E, et al. Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J Biol Chem. 2003;278:51786–95.
   PubMed Web of Science ®Google Scholar
• Seki A, Coppinger JA, Jang CY, Yates JR, Fang G. Bora and the kinase Aurora A cooperatively activate the kinase Plk1 and control mitotic entry. Science. 2008;320:1655–58.
   PubMed Web of Science ®Google Scholar
• Song SJ, Song MS, Kim SJ, Kim SY, Kwon SH, Kim JG, et al. Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity. Cancer Res. 2009;69:2314–23.
   PubMed Web of Science ®Google Scholar
• Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998;20:189–93.
   PubMed Web of Science ®Google Scholar
• Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998;17:3052–065.
   PubMed Web of Science ®Google Scholar
• Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol. 1999;9:M57–60.
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature. 2005;437:1043–47.
   PubMed Web of Science ®Google Scholar
• Hoar K, Chakravarty A, Rabino C, Wysong D, Bowman D, Roy N, et al. MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy. Mol Cell Biol. 2007;27:4513–25.
   PubMed Web of Science ®Google Scholar
• Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J. 2002;21:483–92.
   PubMed Web of Science ®Google Scholar
• Katsetos CD, Dráberová E, Legido A, Dumontet C, Dráber P. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin. J Cell Physiol. 2009;221:505–13.
   PubMed Web of Science ®Google Scholar
• Niu Y, Liu T, Tse GM, Sun B, Niu R, Li HM, et al. Increased expression of centrosomal alpha, gamma-tubulin in atypical ductal hyperplasia and carcinoma of the breast. Cancer Sci. 2009;100:580–7.
   PubMed Web of Science ®Google Scholar
• Liu T, Niu Y, Yu Y, Liu Y, Zhang F. Increased gamma-tubulin expression and P16INK4A promoter methylation occur together in preinvasive lesions and carcinomas of the breast. Ann Oncol. 2009;20:441–8.
   PubMed Web of Science ®Google Scholar
• Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, Kurnit DM, et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res. 2001;61:6885–91.
   PubMed Web of Science ®Google Scholar
• Loh JK, Lieu AS, Chou CH, Lin FY, Wu CH, Howng SL, et al. Differential expression of centrosomal proteins at different stages of human glioma. BMC Cancer. 2010;10:268–75.
   PubMedGoogle Scholar
• Loh JK, Lieu AS, Chou CH, Lin CC, Yang MC, Lin FY, et al. Differential expression of centrosome-associated proteins in human brain tumors: a possible role of hNinein isoform 6 in cell differentiation. Biofactors. 2012;38:470–7.
   PubMed Web of Science ®Google Scholar
• Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215–29.
   PubMed Web of Science ®Google Scholar
• Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;2:187–93.
   PubMed Web of Science ®Google Scholar
• Katsetos CD, Dráberová E, Legido A, Dráber P. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin. J Cell Physiol. 2009;221:514–20.
   PubMed Web of Science ®Google Scholar
• Barton VN, Foreman NK, Donson AM, Birks DK, Handler MH, Vibhakar R. Aurora kinase A as a rational target for therapy in glioblastoma. J Neurosurg Pediatr. 2010;6:98–105.
   PubMed Web of Science ®Google Scholar
• Borges KS, Castro-Gamero AM, Moreno DA, da Silva Silveira V, Brassesco MS, de Paula Queiroz RG, et al. Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. J Cancer Res Clin Oncol. 2012;138:405–14.
   PubMed Web of Science ®Google Scholar
• Katsetos CD, Reddy G, Dráberová E, Smejkalová B, Del Valle L, Ashraf Q, et al. Altered cellular distribution and subcellular sorting of gamma-tubulin in diffuse astrocytic gliomas and human glioblastoma cell lines. J Neuropathol Exp Neurol. 2006;65: 465–77.
   PubMed Web of Science ®Google Scholar
• Loh JK, Lieu AS, Chou CH, Lin CC, Yang MC, Lin FY, et al. Differential expression of centrosome-associated proteins in human brain tumors: a possible role of hNinein isoform 6 in cell differentiation. Biofactors. 2012;38:470–7.
   PubMed Web of Science ®Google Scholar
• Loh JK, Lieu AS, Chou CH, Lin FY, Wu CH, Howng SL, et al. Differential expression of centrosomal proteins at different stages of human glioma. BMC Cancer. 2010;10:268.
   PubMedGoogle Scholar
• Lehman NL, O’Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, et al. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas. Cell Cycle. 2012;11:489–502.
   PubMed Web of Science ®Google Scholar
• El-Sheikh A, Fan R, Birks D, Donson A, Foreman NK, Vibhakar R. Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines. Pediatr Blood Cancer. 2010;55:35–41.
   PubMed Web of Science ®Google Scholar